HomeProductsBioactive CompoundsTarget & Pathway ModulatorsSigma ReceptorCAS 359625-79-9
Chemical structure of CAS 359625-79-9

2-((1-(2-(4-Fluorophenyl)-2-oxoethyl)-4-piperidinyl)methyl)-2,3-dihydro-1H-isoindol-1-one

CAS No.359625-79-9
MDL No.MFCD28502826
MFC22H23FN2O2
MW366.40
InChI KeyRNRYULFRLCBRQS-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.359625-79-9
Product Name2-((1-(2-(4-Fluorophenyl)-2-oxoethyl)-4-piperidinyl)methyl)-2,3-dihydro-1H-isoindol-1-one

Associated Conditions

schizophrenia
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Long-term effects of Roluperidone on negative symptoms of schizophrenia.

Schizophrenia research • Vol. 255 • 2023
PMID: 36933291DOI: 10.1016/j.schres.2023.03.028

Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia.

Schizophrenia bulletin • Vol. 48, Issue 3 • 2022
PMID: 35211743PMC: PMC9077422DOI: 10.1093/schbul/sbac013

Structures of the σ receptor enable docking for bioactive ligand discovery.

Nature • Vol. 600, Issue 7890 • 2021
PMID: 34880501PMC: PMC8867396DOI: 10.1038/s41586-021-04175-x

Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.

The American journal of psychiatry • Vol. 174, Issue 12 • 2017
PMID: 28750582DOI: 10.1176/appi.ajp.2017.17010122

Documentation